Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (opens new window)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Source‎: Int J Gynaecol Obstet 2016;134(3):324-8.

Indexed‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (opens new window)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (opens new window)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Source‎: Cochrane Database Syst Rev 2018;4:CD011689.

Indexed‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (opens new window)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (opens new window)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Source‎: Am J Obstet Gynecol.

Indexed‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (opens new window)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (opens new window)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Source‎: S Afr Med J 2016;106(4):399-402.

Indexed‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (opens new window)

Prophylactic use of ergot alkaloids in the third stage of labour. (opens new window)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Source‎: Cochrane Database Syst Rev 2007;(2):CD005456.

Indexed‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (opens new window)

Treatment for primary postpartum haemorrhage. (opens new window)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Source‎: Cochrane Database Syst Rev 2014;(2):CD003249.

Indexed‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (opens new window)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (opens new window)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Source‎: Obstet Gynecol 2001;98(3):386-90.

Indexed‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (opens new window)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (opens new window)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Source‎: Int J Gynaecol Obstet 2014;127(2):175-9.

Indexed‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (opens new window)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (opens new window)

Ragab A, Barakat R, Alsammani MA.

Source‎: Int J Gynaecol Obstet 2016;132(1):82-4.

Indexed‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (opens new window)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (opens new window)

Roach MK, Abramovici A, Tita AT.

Source‎: Am J Perinatol 2013;30(7):523-8.

Indexed‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (opens new window)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (opens new window)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Source‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

Indexed‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (opens new window)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (opens new window)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Source‎: Lancet Glob Health. 2023 11(2):e287-e295.

Indexed‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (opens new window)

Intravenous sulprostone infusion in the treatment of retained placenta. (opens new window)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Source‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

Indexed‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (opens new window)

Carbetocin for preventing postpartum haemorrhage. (opens new window)

Su LL, Chong YS, Samuel M.

Source‎: Cochrane Database Syst Rev 2012;(4):CD005457.

Indexed‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (opens new window)

Prostaglandins for preventing postpartum haemorrhage. (opens new window)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Source‎: Cochrane Database Syst Rev 2012;(8):CD000494.

Indexed‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (opens new window)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (opens new window)

Westhoff G, Cotter AM, Tolosa JE.

Source‎: Cochrane Database Syst Rev 2013;(10):CD001808.

Indexed‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (opens new window)